(Q50643195)

17 March 2018

title

Economic evaluation of end stage renal disease treatment. (English)

1 reference

17 March 2018

1 reference

de Wit GA

1

1 reference

17 March 2018

Ramsteijn PG

series ordinal

2

1 reference

17 March 2018

de Charro FT

series ordinal

3

1 reference

17 March 2018

publication date

1 June 1998

1 reference

17 March 2018

published in

Health Policy

1 reference

17 March 2018

volume

44

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

215-232

1 reference

17 March 2018

Prolonged survival of human-kidney homografts by immunosuppressive drug therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Cost-benefit analysis of long-term haemodialysis for chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Cost-effectiveness analysis of end-stage renal disease treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Cost-effective care of end-stage renal disease: a billion dollar question

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

A study of the quality of life and cost-utility of renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

An economic evaluation of hospital-based hemodialysis and home-based peritoneal dialysis for pediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

EuroQol: the current state of play

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Whose utilities for decision analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

The utility of different health states as perceived by the general public

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

The time trade-off method: results from a general population study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Modeling valuations for EuroQol health states

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

The quality of life of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Quality of life in end-stage renal disease: a reexamination

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Markov models in medical decision making: a practical guide.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

A comparison of charges for continuous ambulatory peritoneal dialysis and center hemodialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

Report on management of renale failure in Europe, XXVI, 1995. Report based on the Centre Questionnaire, 1995. The ERA-EDTA Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8510%2898%2900017-7

7 January 2021

10.1016/S0168-8510(98)00017-7

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018